Gastric Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) 18 years ~ 75 years; (2) the primary adenocarcinoma (papillary adenocarcinoma, tubular adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma, poorly differentiated adenocarcinoma); (3) clinical stage T2-4a, N0-3, M0 (according to AJCC-7th TNM staging); (4) to perform distal gastrectomy, D2 lymph node dissection surgical can obtain R0 resection (multiple primary cancers also apply) (5) ECOG performance status 0/1; (6) ASA score I-III; (7) patient informed consent.
Exclusion criteria
Exclusion criteria: (1) pregnant or lactating women; (2) serious mental illness; (3) upper abdominal surgery (except laparoscopic cholecystectomy ); (4) gastric surgery (including for gastric ESD / EMR); (5)imaging examinations showed regional integration lymph nodes (maximum diameter = 3cm) (6) other malignant diseases in 5 years; (7) implemented or recommended neoadjuvant therapy in patients with gastric cancer ; (8) have unstable angina or myocardial infarction within six months; (9) have cerebral infarction or cerebral hemorrhage within 6 months; (10) sustained systemic glucocorticoid treatment history within 1 month; (11) have other diseases needed operative treatment at the same time; (12) complications (bleeding, perforation, obstruction) required emergency surgery; (13) Pulmonary function tests FEV1 <50% of predicted value.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year disease free survival rat; | — |
Countries
China